
|Articles|October 1, 2004
Implant shows success in treating posterior uveitis
Durham, NC-Results of a 9-month randomized, dose-masked, multicenter clinical trial of a fluocinolone acetonide sustained drug delivery system to treat posterior uveitis resulted in significant gains for the eyes that received implants when compared with fellow eyes that did not receive implants, said Glenn J. Jaffe, MD.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
AAO 2025: Philip J. Ferrone, MD, highlights safety and efficacy findings of gildeuretinol in Stargardt disease
2
News from Orlando: AAO 2025 highlights research across all areas of eyecare
3
AAO 2025: Glaucoma laser surgery with Joel S. Schuman, MD, FACS
4
AAO 2025: Which lens to consider in patients with pseudoexfoliation
5